440 Mg Trastuzumab For Injection

Name: 440 Mg Trastuzumab For Injection
Brand: NEETCO BIOPHARMA
Price: 20000 INR
Availability: InStock

Price 20000 INR/ Box

Get a Price/Quote

MOQ : 1 Box

440 Mg Trastuzumab For Injection Specification

Dosage Form
Lyophilized Powder for Injection

Salt Composition
Trastuzumab 440 mg

Indication
Breast cancer and gastric cancer with HER2 overexpression

Enzyme Types
Monoclonal antibody (not an enzyme)

Feature
High purity, specific targeting of HER2 protein, enhances clinical outcomes in HER2 positive cancers

Ingredients
Trastuzumab, excipients (L-histidine, L-histidine hydrochloride, polysorbate 20, ,-trehalose dihydrate)

Application
Intravenous infusion

Ph Level
Between 5.5 to 6.5 (after reconstitution)

Temperature Needed For Fermentation
Not applicable (biotechnological process)

Physical Color/Texture
White to pale yellow lyophilized cake or powder

Fermentation Smell
Odorless

Enzymatic Activity
Not enzyme, antibody activity

Storage Instructions
Store at 2C to 8C, do not freeze

Shelf Life
24 months from manufacturing date when refrigerated

About 440 Mg Trastuzumab For Injection

Take advantage of the ace solution for HER2 positive cancer treatment with 440 Mg Trastuzumab For Injection. This crowning antineoplastic monoclonal antibody, presented as a majestic white to pale yellow lyophilized powder, capitalises on specific HER2 protein targeting to improve survival rates in eligible breast and gastric cancer patients. Packaged in a popular single-dose vial, it must be reconstituted with sterile water and administered intravenously under a qualified healthcare professional's supervision. Ensure optimal outcomes by strictly following prescription guidelines and professional reconstitution instructions. Store refrigerated for maximum shelf life.

Distinct Features, Direction, and Applications

440 Mg Trastuzumab For Injection offers popular high-purity targeting of HER2, making it an ace component in cancer therapy machines. To use, reconstitute the vial with sterile water and infuse intravenously as directed. Usage includes treatment of HER2 positive breast and gastric cancer, delivered only under professional supervision. The majestic white or pale yellow powder is specifically designed for safe hospital and oncology settings, ensuring precise administration and exceptional clinical results.

Export Markets, Logistics, and Delivery

440 Mg Trastuzumab For Injection is highly sought after in major export markets across Asia, Africa, and Europe. We efficiently manage logistics from India, coordinating secure drop-off through reputable FOB ports. Delivery times are streamlined for international clients, ensuring quick and reliable shipment whilst maintaining product integrity through every step of the process. Our export network prioritises timely arrivals and compliance for global healthcare institutions.

FAQ's of 440 Mg Trastuzumab For Injection:

Q: How should 440 Mg Trastuzumab For Injection be prepared before administration?

A: Reconstitute the vial with the recommended volume of sterile water for injection according to the official preparation instructions. Use immediately after reconstitution or within the stated stability period to ensure efficacy.

Q: What cancers is this Trastuzumab formulation indicated for?

A: 440 Mg Trastuzumab For Injection is specifically indicated for breast cancer and gastric cancer cases exhibiting HER2 overexpression, offering targeted therapeutic benefits in these patient groups.

Q: Where should the product be stored to maintain its shelf life?

A: Store the vial refrigerated between 2C to 8C and avoid freezing. Proper storage guarantees a shelf life of 24 months from the manufacturing date, helping preserve its clinical effectiveness.

Q: When should the product be administered after reconstitution?

A: The solution should be administered immediately after reconstitution. If immediate use is not possible, it must be used within the stated period of stability to ensure safety and potency.

Q: What process must be followed to administer this medication?

A: It must be prepared as instructed and administered solely via intravenous infusion under the supervision of a qualified healthcare professional, ensuring patient safety and optimal outcomes.

Q: How does this product benefit eligible cancer patients?

A: By specifically targeting the HER2 protein, Trastuzumab enhances clinical outcomes, significantly improving survival rates when used with chemotherapy in eligible breast and gastric cancer patients.

Tell us about your requirement